We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

A Unique Streptococcus Strain Now Dominates the Infection Landscape in the United Kingdom

By LabMedica International staff writers
Posted on 05 Aug 2015
British microbiologists have identified the mutations that were responsible for the dramatic increase in virulence of a Group A Streptococcus (GAS) variant that has now emerged as the dominant strain in the United Kingdom.

Investigators at Imperial College London (United Kingdom) used whole-genome sequencing techniques to analyze changes in the genome of GAS genotype emm89. A sharp rise in the number of infections caused by this particular strain was observed from 1998 to 2009.

Image: Photomicrograph shows Streptococcus genotype emm89, which is typified by its lack of the hyaluronic acid capsule (Photo courtesy of Imperial College London).
Image: Photomicrograph shows Streptococcus genotype emm89, which is typified by its lack of the hyaluronic acid capsule (Photo courtesy of Imperial College London).

Results of whole-genome sequencing revealed that although standard variable typing regions (emm subtype, tee type, sof type, and multilocus sequence typing [MLST]) remained unchanged, this unique subtype had undergone six distinct regions of homologous recombination across the genome compared to the rest of the sequenced emm89 population. Two of these regions affected known virulence factors, the hyaluronic acid capsule and the toxins NADase and streptolysin O.

Loss of the hyaluronic acid capsule was a particularly surprising finding, as it had been believed by microbiologists that the capsule was essential for GAS bacteria to cause invasive disease.

Senior author Dr. Shiranee Sriskandan, professor of medicine at Imperial College London, said, "This discovery was made possible thanks to the cooperation of our hospital diagnostic lab and the national reference lab, which helped us to spot a pattern locally and then study it nationally. We know very little about how group A Streptococcus is transmitted from person to person. We need to look into this more deeply and think about better ways to prevent transmission. Luckily, the new variant remains exquisitely sensitive to penicillin and related antibiotics. But we also need to think about whether our treatment strategies are as good as they can be."

The work was published in the July 14, 2015, online edition of the journal mBio.

Related Links:

Imperial College London



New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit

Latest Microbiology News

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment